Effect of smoking on breast cancer in carriers of mutant BRCA1 or BRCA2 genes.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Journal of the National Cancer Institute

• Publication date

  1998-05-20

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/JNCI/90.10.761PMID 9605646
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Correspondence re: G. C. Kabat et al., Urinary estrogen metabolites and breast cancer: a case-control study. Cancer Epidemiol., Biomark. Prev., 6: 505-509, 1997.

  1998cited by this paper
• Almost Exclusive Androgenic Action of Dehydroepiandrosterone in the Rat Mammary Gland.

  1998cited by this paper
• Birthweight as risk factor for breast cancer.

  1997cited by this paper
• Birthweight as risk factor for breast cancer (multiple letters) [1]

  1997cited by this paper
• BIRTHWEIGHT AS RISK FACTOR FOR BREAST CANCER. AUTHORS' REPLY

  1997cited by this paper
• (S)-(+)-4-[7-(2,2-dimethyl-1-oxopropoxy)-4-methyl-2-[4-[2-(1-piperidinyl)-ethoxy]phenyl]-2H-1-benzopyran-3-yl]-phenyl 2,2-dimethylpropanoate (EM-800): a highly potent, specific, and orally active nonsteroidal antiestrogen.

  1997cited by this paper
• Brithweight as risk factor for breast cancer

  1997cited by this paper
• The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews.

  1997cited by this paper
• Bone mass and the risk of breast cancer among postmenopausal women.

  1997cited by this paper
• Genetic polymorphisms and breast cancer risk.

  1997cited by this paper
• Characterization of the effects of the novel non‐steroidal antiestrogen EM‐800 on basal and estrogen‐induced proliferation of T‐47D, ZR‐75‐1 and MCF‐7 human breast cancer cells in vitro

  1997cited by this paper
• Effect of Dehydroepiandrosterone on Bone Mass, Serum Lipids, and Dimethylbenz(a)anthracene-Induced Mammary Carcinoma in the Rat.

  1997cited by this paper
• Birthweight as a risk factor for breast cancer

  1997cited by this paper
• Variation of risks of breast and ovarian cancer associated with different germline mutations of the BRCA2 gene

  1997cited by this paper
• Urinary estrogen metabolites and breast cancer: a case-control study.

  1997cited by this paper
• High bioavailability of dehydroepiandrosterone administered percutaneously in the rat.

  1996cited by this paper
• Cigarette smoking, N-acetyltransferase 2 genetic polymorphisms, and breast cancer risk.

  1996cited by this paper
• Birthweight as a risk factor for breast cancer.

  1996cited by this paper
• Cigarette smoking and breast cancer.

  1996cited by this paper
• BRCA1 testing in families with hereditary breast-ovarian cancer. A prospective study of patient decision making and outcomes.

  1996cited by this paper
• Five versus more than five years of tamoxifen therapy for breast cancer patients with negative lymph nodes and estrogen receptor-positive tumors.

  1996cited by this paper
• The 3β-Hydroxysteroid Dehydrogenase/Isomerase Gene Family: Lessons from Type II 3β-HSD Congenital Deficiency

  1996cited by this paper
• Comparison of the effects of a pure steroidal antiestrogen with those of tamoxifen in a model of human breast cancer.

  1995cited by this paper
• Risk modifiers in carriers of brca1 mutations

  1995cited by this paper
• Hormonal treatment of advanced breast cancer.

  1995cited by this paper
• Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium.

  1995cited by this paper
• DHEA and Peripheral Androgen and Estrogen Formation: Intracrinology

  1995cited by this paper
• A large multisite cancer family is linked to BRCA2.

  1995cited by this paper
• Serum insulin‐like growth factor I in a random population sample of men and women: relation to age, sex, smoking habits, coffee consumption and physical activity, blood pressure and concentrations of plasma lipids, fibrinogen, parathyroid hormone and osteocalcin

  1994cited by this paper
• Serum insulin-like growth factor-I in 1030 healthy children, adolescents, and adults: relation to age, sex, stage of puberty, testicular size, and body mass index.

  1994cited by this paper
• Cigarette smoking and risk of fatal breast cancer.

  1994cited by this paper
• Androgen receptor gene mutation in male breast cancer.

  1993cited by this paper
• Plasma insulin-like growth factor-1 (IGF-1) concentrations in human breast cancer.

  1993cited by this paper
• The impact of cigarette smoking on the plasma concentrations of gonadotrophins, ovarian steroids and androgens and upon the metabolism of oestrogens in the human female.

  1993cited by this paper
• Control of aromatase in breast cancer cells and its importance for tumor growth.

  1993cited by this paper
• A germline mutation in the androgen receptor gene in two brothers with breast cancer and Reifenstein syndrome

  1992cited by this paper
• Smoking effects on the hormonal balance of fertile women.

  1992cited by this paper
• ICI 182,780, a new antioestrogen with clinical potential.

  1992cited by this paper
• Acquired tamoxifen resistance: correlation with reduced breast tumor levels of tamoxifen and isomerization of trans-4-hydroxytamoxifen.

  1991cited by this paper
• Additive inhibitory effects of an androgen and the antiestrogen EM-170 on estradiol-stimulated growth of human ZR-75-1 breast tumors in athymic mice.

  1991cited by this paper
• Androgen sensitivity of the new human breast cancer cell line MFM-223.

  1991cited by this paper
• Combination hormonal therapy with tamoxifen plus fluoxymesterone versus tamoxifen alone in postmenopausal women with metastatic breast cancer. An updated analysis

  1991cited by this paper
• Regulation of progesterone-binding breast cyst protein GCDFP-24 secretion by estrogens and androgens in human breast cancer cells: a new marker of steroid action in breast cancer.

  1990cited by this paper
• The antiestrogenic effect of cigarette smoking in women.

  1990cited by this paper
• The Older Smoker: Status, Challenges and Opportunities for Intervention

  1990cited by this paper
• Cigarette smoking and breast cancer.

  1989cited by this paper
• Inhibitory effect of estrogens on GCDFP-15 mRNA levels and secretion in ZR-75-1 human breast cancer cells.

  1989cited by this paper
• Inhibition of tamoxifen-stimulated growth of an MCF-7 tumor variant in athymic mice by novel steroidal antiestrogens.

  1989cited by this paper
• Additive inhibitory effects of bromocryptine (CB-154) and medroxyprogesterone acetate (MPA) on dimethylbenz[a]anthracene (DMBA)-induced mammary tumors in the rat.

  1989cited by this paper
• The role of estrogens in growth regulation of breast cancer.

  1989cited by this paper
• Antagonism between estrogens and androgens on GCDFP-15 gene expression in ZR-75-1 cells and correlation between GCDFP-15 and estrogen as well as progesterone receptor expression in human breast cancer.

  1989cited by this paper
• Contrasting actions of tamoxifen on endometrial and breast tumor growth in the athymic mouse.

  1988cited by this paper
• Androgenic activity of dehydroepiandrosterone and androstenedione in the rat ventral prostate.

  1988cited by this paper
• Cigarette smoking and the risk of endometrial cancer.

  1987cited by this paper
• Human breast cancer in the athymic nude mouse: cytostatic effects of long-term antiestrogen therapy.

  1987cited by this paper
• Increased 2-hydroxylation of estradiol as a possible mechanism for the anti-estrogenic effect of cigarette smoking.

  1986cited by this paper
• Stimulation of cell proliferation and estrogenic response by adrenal C19-delta 5-steroids in the ZR-75-1 human breast cancer cell line.

  1986cited by this paper
• Cigarette smoking and the risk of endometrial cancer.

  1985cited by this paper
• Cigarette smoking, serum estrogens, and bone loss during hormone-replacement therapy early after menopause.

  1985cited by this paper
• Androgen receptor activity in human breast cancer and its relationship with oestrogen and progestogen receptor activity.

  1985cited by this paper
• Androgen receptors in breast cancer

  1984cited by this paper
• Laboratory studies to develop general principles for the adjuvant treatment of breast cancer with antiestrogens: Problems and potential for future clinical applications

  1983cited by this paper
• Evaluation of tamoxifen doses with and without fluoxymesterone in advanced breast cancer.

  1983cited by this paper
• Cigarette smoking and urinary estrogens.

  1982cited by this paper
• Effect of Weight, Smoking, and Estrogen Use on the Risk of Hip and Forearm Fractures in Postmenopausal Women

  1982cited by this paper
• Characteristics of binding to estrogen, androgen, progestin, and glucocorticoid receptors in 7,12-dimethylbenz(a)anthracene-induced mammary tumors and their hormonal control.

  1980cited by this paper
• Inhibition of spontaneous breast cancer formation in female C3H(Avy/a) mice by long-term treatment with dehydroepiandrosterone.

  1979cited by this paper
• Distribution, frequency, and quantitative analysis of estrogen, progesterone, androgen, and glucocorticoid receptors in human breast cancer.

  1979cited by this paper
• Inhibitory Effect of LHRH and Its Agonists on Testicular Gonadotrophin Receptors and Spermatogenesis in the Rat

  1978cited by this paper
• Effects of estradiol and prolactin on steroid receptor levels in 7,12-dimethylbenz(a)anthracene-induced mammary tumors and uterus in the rat.

  1978cited by this paper
• Specific binding of estradiol and dihydrotestosterone in human mammary cancers.

  1977cited by this paper
• The use of androgens in the treatment of neoplastic disease

  1977cited by this paper
• Control of hormone receptor levels and growth of 7,12-dimethylbenz(a)anthracene-induced mammary tumors by estrogens, progesterone and prolactin.

  1977cited by this paper
• Counteraction by prolactin of androgen-induced inhibition of mammary tumor growth in rats.

  1974cited by this paper
• Hormonal therapy in cancer of the breast. I. The effect of testosterone propionate therapy on clinical course and hormonal excretion

  1951cited by this paper
• Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright © 1997 by The Endocrine Society Effect of 12-Month Dehydroepiandrosterone Replacement Therapy on Bone, Vagina, and Endometrium in Postmenopausal Women

  year unknowncited by this paper

• Modifiable risk factors in women at high risk of breast cancer: a systematic review

  2023cites this paper
• Independent of Primary Sclerosing Cholangitis and Cirrhosis, Early Adulthood Obesity is Associated with Cholangiocarcinoma.

  2023cites this paper
• A Brief History of Carbon Monoxide and Its Therapeutic Origins.

  2021cites this paper
• Alcohol Consumption, Cigarette Smoking, and Risk of Breast Cancer for BRCA1 and BRCA2 Mutation Carriers: Results from The BRCA1 and BRCA2 Cohort Consortium

  2019influential citation
• The association between smoking and cancer incidence in BRCA1 and BRCA2 mutation carriers

  2018cites this paper
• BRCA Mutations and Breast Cancer Prevention

  2018cites this paper
• Pattern of breast cancer risk factors among pre and post-menopausal women at a Primary Care Clinic in Nigeria

  2016cites this paper
• Modifiers of breast and ovarian cancer risks for BRCA1 and BRCA2 mutation carriers.

  2016cites this paper
• Associations Between Personal Care Product Use Patterns and Breast Cancer Risk in the Sister Study

  2016cites this paper
• Economic explorations of equality issues across the care pathway in breast cancer

  2015cites this paper
• Epithelial ovarian cancer: An overview.

  2014cites this paper
• Modifiers of cancer risk in BRCA1 and BRCA2 mutation carriers: systematic review and meta-analysis.

  2014cites this paper
• Epidemiología del cáncer de mama

  2013cites this paper
• Étude des facteurs modificateurs du risque de cancer du sein des femmes à risque génétique élevé

  2012influential citation
• Épidémiologie du cancer du sein

  2012cites this paper
• iArc monogrAphs on the evAluAtion oF cArcinogenic risks to humAns

  2012cites this paper
• Influence des hormones stéroïdes et potentiel préventif d'un antiprogestatif, l'ulpristal acétate, dans la tumorigenèse liée à la mutation du gène BRCA1

  2011cites this paper
• Detoxification: A Novel Function of BRCA1 in Tumor Suppression?

  2011cites this paper
• Variation in breast cancer risk with mutation position, smoking, alcohol, and chest X-ray history, in the French National BRCA1/2 carrier cohort (GENEPSO)

  2011cites this paper
• [Clinical-genetic care of BRCA-mutation carrier women: prevention, diagnosis and therapy].

  2011cites this paper
• Active smoking and secondhand smoke increase breast cancer risk: the report of the Canadian Expert Panel on Tobacco Smoke and Breast Cancer Risk (2009)

  2010cites this paper
• Inheritance and the Risk of Breast Cancer

  2010cites this paper
• Evaluation of established breast cancer risk factors as modifiers of BRCA1 or BRCA2: a multi-center case-only analysis

  2010cites this paper
• Smoking and Colorectal Cancer in Lynch Syndrome: Results from the Colon Cancer Family Registry and The University of Texas M.D. Anderson Cancer Center

  2010cites this paper
• Mutagen sensitivity, tobacco smoking and breast cancer risk: a case-control study.

  2010cites this paper
• Weight History, Smoking, Physical Activity and Breast Cancer Risk among French-Canadian Women Non-Carriers of More Frequent BRCA1/2 Mutations

  2009cites this paper
• Genetic Counseling and the Advanced Practice Oncology Nursing Role in a Hereditary Cancer Prevention Clinic: Hereditary Breast Cancer Focus (Part I)

  2009cites this paper
• Genetic Counseling and the Advanced Practice Oncology Nursing Role in a Hereditary Cancer Prevention Clinic: Hereditary Breast Cancer Focus (Part II)

  2009cites this paper
• Canadian Expert Panel on Tobacco Smoke and Breast Cancer Risk

  2009cites this paper
• Basic concepts in the molecular biology of cancer. Genetic susceptibility.

  2009cites this paper
• Smoking and the risk of breast cancer in BRCA1 and BRCA2 carriers: an update

  2009influential citation
• Health behaviors among Ashkenazi Jewish individuals receiving counseling for BRCA1 and BRCA2 mutations

  2009cites this paper
• Refining BRCA1 and BRCA2 penetrance estimates in the clinic

  2009cites this paper
• Smoking and risk of breast cancer in carriers of mutations in BRCA1 or BRCA2 aged less than 50 years

  2008cites this paper
• Morbidity and mortality in relation to smoking among women and men of Chinese ethnicity: the Singapore Chinese Health Study.

  2008cites this paper
• Tabaquismo y cáncer ginecológico. Causalidad y pronóstico

  2008cites this paper
• Prevalence of pre-malignant and malignant lesions in prophylactic mastectomy specimens of BRCA1 mutation carriers: comparison with a control group

  2008cites this paper
• Variation in breast cancer risk in BRCA1 and BRCA2 mutation carriers

  2008cites this paper
• Étude des effets endocriniens produits par les organochlorés en lien avec la carcinogenèse mammaire

  2008cites this paper
• No Sib Pair Concordance for Breast or Ovarian Cancer in BRCA1 Mutation Carriers

  2007cites this paper
• Impact of endocrine disruptor chemicals in gynaecology.

  2007cites this paper
• An unsuspected cause of chronic diarrhoea

  2007cites this paper
• Germline mutations in the tumour suppressor genes breast cancer antigen gene ( BRCA ) 1 and BRCA 2

  2007cites this paper
• Facteurs de risque des cancers du sein familiaux

  2007cites this paper
• Effect of familial history and smoking on common cancer risks in Japan

  2007cites this paper
• Breast Cancer Risk Modifiers

  2007cites this paper
• epidemiologymedicine, and the future: Genetic

  2006cites this paper
• Is the Association between Cigarette Smoking and Breast Cancer Modified by Genotype? A Review of Epidemiologic Studies and Meta-analysis

  2006cites this paper
• Role of BRCA1 and BRCA2 mutations in pancreatic cancer

  2006cites this paper
• The parity-related protection against breast cancer is compromised by cigarette smoke during rat pregnancy: observations on tumorigenesis and immunological defenses of the neonate.

  2006cites this paper
• The joint effect of smoking and AIB1 on breast cancer risk in BRCA1 mutation carriers.

  2006cites this paper
• Estimation of accelerated failure time models with random effects

  2006cites this paper
• Female Breast Cancer: Epidemiological And Clinical Study Of Some Risk Factors Among Egyptian Females- Multi Clinics Study

  2005influential citation
• Weight, weight gain, and survival after breast cancer diagnosis.

  2005cites this paper
• A weighted cohort approach for analysing factors modifying disease risks in carriers of high‐risk susceptibility genes

  2005cites this paper
• Active smoking, household passive smoking, and breast cancer: evidence from the California Teachers Study.

  2004cites this paper
• The role of hypoxia signalling pathways in tumour biology.

  2004cites this paper
• Smoking and the risk of breast cancer among carriers of BRCA mutations

  2004cites this paper
• Epidemiology of breast cancer among BRCA mutation carriers: an overview.

  2004cites this paper
• Passive smoking and breast cancer risk among non‐smoking Chinese women

  2004cites this paper
• A delayed chemically induced tumorigenesis in Brca2 mutant mice

  2004influential citation
• Lifestyle related risk factors for breast cancer in Jordanian females.

  2004cites this paper
• Cytochrome P450 1A2 (CYP1A2) activity and risk factors for breast cancer: a cross-sectional study

  2004cites this paper
• [Are the hereditary forms of BRCA1 and BRCA2 breast cancer sensitive to estrogens?].

  2004cites this paper
• Breast cancer: occurrence, risk factors and hormone metabolism

  2003cites this paper
• Re: Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers.

  2003cites this paper
• Re: Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers.

  2003cites this paper
• Behavioral problems and tobacco use among adolescents in Chile.

  2003cites this paper
• The Norwegian founder mutations in BRCA1: high penetrance confirmed in an incident cancer series and differences observed in the risk of ovarian cancer.

  2003cites this paper
• Does smoking increase the risk of breast cancer?

  2003cites this paper
• Diagnostic génétique du cancer du sein et de l’ovaire héréditaire*

  2003cites this paper
• Enzyme induction and dietary chemicals as approaches to cancer chemoprevention: the Seventh DeWitt S. Goodman Lecture.

  2003cites this paper
• Susceptibility genes in hereditary breast cancer

  2003cites this paper
• Aromatic DNA adducts and polymorphisms of CYP1A1, NAT2, and GSTM1 in breast cancer.

  2002cites this paper
• Cigarette smoking and the risk of breast cancer in women: a review of the literature.

  2002cites this paper
• BRCA-1, BRCA-2 and Hereditary Breast Cancer

  2002cites this paper
• A Null Association between Active or Passive Cigarette Smoking and Breast Cancer Risk

  2002cites this paper
• Genetic epidemiology of melanoma: of consortia and conundrums.

  2002cites this paper
• Tobacco use, cancer causation and public health impact

  2002cites this paper
• Oral contraceptives and risk of familial breast cancer.

  2002cites this paper
• Smoking (active and passive) and breast cancer: Epidemiologic evidence up to June 2001

  2002cites this paper
• The genetics of ovarian cancer.

  2002cites this paper
• Do estrogens always increase breast cancer risk?

  2002cites this paper
• What options for treatment of hereditary breast cancer?

  2002cites this paper
• Cigarette Smoking and the Risk of Breast Cancer in Women

  2002cites this paper
• Germline mutations of BRCA1 and BRCA2 genes - founder effects and contribution to ovarian carcinoma in Finland

  2002cites this paper
• Risk assessment & genetic testing.

  2002cites this paper
• The Molecular Basis of Breast Carcinogenesis

  2002cites this paper
• Sample size and power determination for clustered repeated measurements

  2002cites this paper
• Hereditary breast cancer associated with a germline BRCA2 mutation in identical female twins with similar disease expression.

  2002cites this paper
• Inherited predisposition and breast cancer: Modifiers of BRCA1/2‐associated breast cancer risk

  2002cites this paper
• Prevalence and spectrum of p53 mutations associated with smoking in breast cancer.

  2002cites this paper
• Educational Review: Role of the Surgeon in Hereditary Breast Cancer

  2001cites this paper
• Current perspectives on BRCA1‐ and BRCA2‐associated breast cancers

  2001cites this paper
• Hereditary breast cancer.

  2001cites this paper
• Oral contraceptives and risk of breast cancer in women with a family history of breast cancer

  2001cites this paper
• Clinical management of women with genomic BRCA1 and BRCA2 mutations*

  2001cites this paper
• Hormonal Prevention of Hereditary Breast Cancer

  2001cites this paper
• Cigarette smoking increases risk for breast cancer in high-risk breast cancer families.

  2001cites this paper
• Epidemiology of breast cancer: an environmental disease? Note

  2001cites this paper